Researcher.Life Logo

Journal of Immunotherapy : Impact Factor & More

eISSN: 1537-4513pISSN: 1524-9557

Key Metrics

CiteScore
7.9
Eigenfactor
0.001 - 0.005
H-Index
103
Impact Factor
< 5
SJR
Q1Immunology
SNIP
0.8
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Immunotherapy

Journal of Immunotherapy Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Immunotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Immunotherapy

Integrating Bulk RNA-Seq and Spatial Transcriptomics Data to Reveal Distinct Immune Escape Mechanism and Immunotherapy Based on Post-Translational Modification in Head and Neck Squamous Cell Carcinoma.
  • 24 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Immunoregulatory Cyclophilin A Reprograms the Tumor Immune Microenvironment by Changing the Activation and Exhaustion Profile of T Cells and NK Cells in the Model of Melanoma B16 in Vivo.
  • 3 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Synergistic Effect of Anti-PD-L1 Treatment and CD8+ T-Cell Activating Nanotherapy in Pancreatic Ductal Adenocarcinoma Evaluated via 3D Mathematical Modeling.
  • 1 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Integrated Genomic Analysis Identifies Clinically Relevant Molecular Subtypes and Disulfidptosis-Related Prognostic Signature of Gastric Cancer.
  • 1 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Clinical Efficacy and Safety of Cadonilimab Immunotherapy in Advanced Cervical Cancer: A Retrospective Study.
  • 1 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Clinical Features, Treatment, and Prognosis of Pembrolizumab-Induced Isolated Adrenocorticotropic Hormone Deficiency.
  • 23 Oct 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Integrating Bulk RNA-Seq and Spatial Transcriptomics Data to Reveal Distinct Immune Escape Mechanism and Immunotherapy Based on Post-Translational Modification in Head and Neck Squamous Cell Carcinoma.
  • 24 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Immunoregulatory Cyclophilin A Reprograms the Tumor Immune Microenvironment by Changing the Activation and Exhaustion Profile of T Cells and NK Cells in the Model of Melanoma B16 in Vivo.
  • 3 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Synergistic Effect of Anti-PD-L1 Treatment and CD8+ T-Cell Activating Nanotherapy in Pancreatic Ductal Adenocarcinoma Evaluated via 3D Mathematical Modeling.
  • 1 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Integrated Genomic Analysis Identifies Clinically Relevant Molecular Subtypes and Disulfidptosis-Related Prognostic Signature of Gastric Cancer.
  • 1 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Clinical Efficacy and Safety of Cadonilimab Immunotherapy in Advanced Cervical Cancer: A Retrospective Study.
  • 1 Nov 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Clinical Features, Treatment, and Prognosis of Pembrolizumab-Induced Isolated Adrenocorticotropic Hormone Deficiency.
  • 23 Oct 2025
  • Journal of immunotherapy (Hagerstown, Md. : 1997)

FAQs on Journal of Immunotherapy